Filing Details

Accession Number:
0001104659-13-067810
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-03 19:25:41
Reporting Period:
2013-08-29
Filing Date:
2013-09-03
Accepted Time:
2013-09-03 19:25:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885725 Boston Scientific Corp BSX Surgical & Medical Instruments & Apparatus (3841) 042695240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224108 D Jeffrey Capello One Boston Scientific Place
Natick MA 01760-1537
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-08-29 50,000 $10.71 147,447 No 4 S Direct
Common Stock Acquisiton 2013-08-29 86,538 $7.41 233,985 No 4 M Direct
Common Stock Disposition 2013-08-29 86,538 $10.70 147,447 No 4 S Direct
Common Stock Acquisiton 2013-08-29 388,462 $7.41 535,909 No 4 M Direct
Common Stock Disposition 2013-08-29 388,462 $10.67 147,447 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-08-29 86,538 $0.00 86,538 $7.41
Common Stock Stock Option (Right to Buy) Disposition 2013-08-29 388,462 $0.00 388,462 $7.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,847 2020-02-16 No 4 M Direct
130,769 2020-02-16 No 4 M Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.70 to $10.715 per share. The reporting person undertakes to provide, upon request by an appropriate entity or person, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.64 to $10.715 per share. The reporting person undertakes to provide, upon request by an appropriate entity or person, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  3. Grant to reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the grant.